Cell Morphology Meta-Feature Aggregation for Heterogeneous Population Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

High-content morphological analysis of heterogeneous cell populations, such as cardiomyocytes, poses challenges due to intrinsic variations in parameters like cell size, making it difficult to extract meaningful information for drug discovery and disease profiling.

Innovation Solution

A method involving the determination of meta-features by exposing test samples to substances, calculating feature values from clusters of correlated parameters, and comparing these values to control samples to assess the effect of test substances on cardiomyocytes, using machine-readable instructions and image analysis to identify relevant parameters and meta-features.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If high-content morphological analysis is performed on heterogeneous cell populations, then the quantity of extracted parameters increases, but the difficulty of detecting and measuring meaningful information worsens due to intrinsic variations in parameters like cell size

Engineering Contradiction:
Improvenumber of extracted parametersVSAvoiddifficulty of extracting meaningful information
Core Design Contradiction:
Quantity of substanceVSDifficulty of detecting and measuring

Solution Approach 1:

The patent transforms individual cell parameters into population-level meta-features by applying statistical transformations (mean, median, standard deviation, etc.). This changes the parameter representation from raw morphological measurements to standardized statistical descriptors that are comparable across heterogeneous cell populations, thereby resolving the contradiction between extracting many parameters and detecting meaningful information.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces meta-features as an intermediary layer between raw cell parameters and biological interpretation. These meta-features aggregate and normalize parameter variations, serving as a mediator that translates heterogeneous single-cell data into homogeneous population-level characteristics suitable for drug response assessment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If single-cell level parameters are used for analysis, then the precision of individual cell measurement is improved, but the reliability of population-level assessment worsens due to large variations in parameters like cell size

Engineering Contradiction:
Improveprecision of single-cell parameter measurementVSAvoidreliability of population-level assessment
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent merges multiple single-cell parameters and aggregates them into population-level meta-features. By combining individual cell measurements into statistical descriptors (mean, median, standard deviation), the method preserves the precision of single-cell measurements while achieving reliable population-level assessment through ensemble statistics that cancel out individual variations.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent transforms individual cell parameters into population-level meta-features by applying statistical transformations. This parameter change from raw measurements to statistical descriptors enables reliable population-level assessment while maintaining the precision information from individual cell measurements through the statistical aggregation process.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If automated high-content analysis is implemented, then the productivity of cell sample analysis is improved, but the device complexity worsens due to the need for sophisticated image processing and parameter extraction systems

Engineering Contradiction:
Improvespeed of cell sample analysisVSAvoidcomplexity of image processing system
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the complex analysis process into distinct modular stages: image acquisition, parameter extraction, meta-feature calculation, and statistical analysis. This segmentation allows each module to be independently optimized and maintained, reducing overall system complexity while preserving high productivity through automated processing pipelines.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20230352149A1Single-cell morphology analysis for disease profiling and drug discovery
Publication Date: 2023.11.02 UNIVERSITY OF HEIDELBERG
  • US20230352149A1 patent drawing
  • US20230352149A1 patent drawing
  • US20230352149A1 patent drawing

AI summary

The present invention provides method of studying an effect of a test substance on a test sample of bio-logical cells using a set of relevant parameters and a set of meta-features, the method comprising:exposing the test sample to the test substance;determining parameter values of the set of relevant parameters for each of a plurality of cells in the test sample; anddetermining feature values of the set of meta-features for the test sample, wherein each of the feature values is calculated from the parameter values of a cluster of correlated parameters from the set of relevant parameters that is associated with the respective meta-feature,wherein a reference sample for determining the set of meta-features was exposed to a stimulus substance.